Policy Recommendations Georgia

2019-2020 Improvements and Recommendations for Georgia

In 2020, the USDA approved Georgia's hemp production program, allowing in-state cultivation of hemp that will increase the supply and ultimately reduce the price of CBD oil for Georgia patients. In the meantime, eligible Georgia patients remain without an in-state source to the low-THC and high-CBD cannabis products authorized by the state, making safe and legal access extremely difficult. In addition to getting the in-state production, distribution and retail of authorized medical products off of the ground, ASA encourages Georgia to greatly improve its program by strengthening product safety standards, increasing the forms of medical cannabis and medical cannabis products available to patients, and removing arbitrary limits on products' THC percentage. Georgia organized no emergency COVID provisions to maintain or expand medical cannabis access.